Showing results (11-20 of 59) with videos related to
Sort By:
Pageof 6
Blood|November 3, 2007
Redistribution of accumulated cell iron: a modality of chelation with therapeutic implicationsYang-Sung Sohn, William Breuer, Arnold Munnich, et al.Hematology (Amsterdam, Netherlands)|September 29, 2005
Iron overload and chelationChaim Hershko, Gabriela Link, Abraham M Konijn, et al.Blood|July 16, 2005
Intracellular labile iron pools as direct targets of iron chelators: a fluorescence study of chelator action in living cellsHava Glickstein, Rinat Ben El, Maya Shvartsman, et al.Analytical Biochemistry|April 24, 2002
A review of fluorescence methods for assessing labile iron in cells and biological fluidsBreno P Espósito, Silvina Epsztejn, William Breuer, et al.American Journal of Physiology. Cell Physiology|August 3, 2007
Non-transferrin-bound iron reaches mitochondria by a chelator-inaccessible mechanism: biological and clinical implicationsMaya Shvartsman, Raghavendra Kikkeri, Abraham Shanzer, et al.Annals of the New York Academy of Sciences|December 13, 2005
Objectives and mechanism of iron chelation therapyChaim Hershko, Gabriela Link, Abraham M Konijn, et al.Frontiers in Pharmacology|January 16, 2014
Regional siderosis: a new challenge for iron chelation therapyZvi Ioav Cabantchik, Arnold Munnich, Moussa B Youdim, et al.Clinical Therapeutics|September 10, 2013
New pharmacological options for treating advanced Parkinson's diseaseDavid Devos, Caroline Moreau, Kathy Dujardin, et al.American Journal of Hematology|December 24, 2022
The clinical relevance of detectable plasma iron species in iron overload states and subsequent to intravenous iron-carbohydrate administrationMaciej W Garbowski, Ioav Cabantchik, Chaim Hershko, et al.Current Hematology Reports|February 22, 2005
Iron chelation therapyChaim M Hershko, Gabriela M Link, Abraham M Konijn, et al.Pageof 6